enVVeno Medical Corporation - Warrants (30/05/2023)
NVNOW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.37K
Close$
$0.18
2761.9% upside
Current Fair Value
2761.9% upsideUndervalued by 2761.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4,372.00 |
|---|---|
| Enterprise Value | $-2,331,628.00 |
| Earnings per Share | $-33.06 |
| Beta | 1.24 |
| Outstanding Shares | 694,000 |
Return
| Return on Equity | -75.24% |
|---|---|
| Return on Assets | -68.63% |
| Return on Invested Capital | -78.97% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.73 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.35 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About enVVeno Medical Corporation
19 employees
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product c...